EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $7,753,000 | +63.8% | 130,000 | +116.7% | 2.74% | +38.7% |
| Q2 2017 | $4,733,000 | +14.1% | 60,000 | +20.0% | 1.98% | -4.2% |
| Q1 2017 | $4,147,000 | +4.5% | 50,000 | 0.0% | 2.06% | -11.7% |
| Q4 2016 | $3,967,000 | -19.0% | 50,000 | -28.6% | 2.34% | -8.9% |
| Q3 2016 | $4,900,000 | +152.6% | 70,000 | +40.0% | 2.56% | +97.8% |
| Q2 2016 | $1,940,000 | -20.2% | 50,000 | -16.7% | 1.30% | -14.5% |
| Q1 2016 | $2,430,000 | -67.8% | 60,000 | -29.4% | 1.52% | -51.9% |
| Q4 2015 | $7,537,000 | +39.1% | 85,000 | +16.1% | 3.15% | +18.1% |
| Q3 2015 | $5,419,000 | +34.0% | 73,200 | +46.4% | 2.67% | +65.8% |
| Q2 2015 | $4,043,000 | – | 50,000 | – | 1.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |